Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Hackl

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Cancer Immunology, Immunotherapy : CII|September 19, 2012
Bioinformatics for cancer immunology and immunotherapyPornpimol Charoentong, Mihaela Angelova, Mirjana Efremova, et al.
FEMS Microbiology Ecology|May 13, 2016
Formation of lipid bodies and changes in fatty acid composition upon pre-akinete formation in Arctic and Antarctic Zygnema (Zygnematophyceae, Streptophyta) strainsMartina Pichrtová, Erwann Arc, Wolfgang Stöggl, et al.
Pharmacology & Therapeutics|September 14, 2010
Information technology solutions for integration of biomolecular and clinical data in the identification of new cancer biomarkers and targets for therapyHubert Hackl, Gernot Stocker, Pornpimol Charoentong, et al.
Cells|October 13, 2023
Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative ThrombocytopeniaAnita Pirabe, Sabine Frühwirth, Laura Brunnthaler, et al.
International Journal of Medical Microbiology : IJMM|February 10, 2015
Differential gene expression in Aspergillus fumigatus induced by human platelets in vitroSusanne Perkhofer, Christoph Zenzmaier, Emilie Frealle, et al.
BMC Genomics|December 14, 2004
GOLD.db: genomics of lipid-associated disorders databaseHubert Hackl, Michael Maurer, Bernhard Mlecnik, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2025
Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancerKatharina Steger, Heidelinde Fiegl, Barin Feroz, et al.
Histochemistry and Cell Biology|February 2, 2012
Differential response of arterial and venous endothelial cells to extracellular matrix is modulated by oxygenLuciana Lassance, Heidi Miedl, Viktoria Konya, et al.
BMC Cancer|January 5, 2018
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)Florian Huemer, Josef Thaler, Gudrun Piringer, et al.
Cell Reports|January 5, 2017
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadePornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|September 19, 2012
Bioinformatics for cancer immunology and immunotherapyPornpimol Charoentong, Mihaela Angelova, Mirjana Efremova, et al.
FEMS Microbiology Ecology|May 13, 2016
Formation of lipid bodies and changes in fatty acid composition upon pre-akinete formation in Arctic and Antarctic Zygnema (Zygnematophyceae, Streptophyta) strainsMartina Pichrtová, Erwann Arc, Wolfgang Stöggl, et al.
Pharmacology & Therapeutics|September 14, 2010
Information technology solutions for integration of biomolecular and clinical data in the identification of new cancer biomarkers and targets for therapyHubert Hackl, Gernot Stocker, Pornpimol Charoentong, et al.
Cells|October 13, 2023
Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative ThrombocytopeniaAnita Pirabe, Sabine Frühwirth, Laura Brunnthaler, et al.
International Journal of Medical Microbiology : IJMM|February 10, 2015
Differential gene expression in Aspergillus fumigatus induced by human platelets in vitroSusanne Perkhofer, Christoph Zenzmaier, Emilie Frealle, et al.
BMC Genomics|December 14, 2004
GOLD.db: genomics of lipid-associated disorders databaseHubert Hackl, Michael Maurer, Bernhard Mlecnik, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2025
Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancerKatharina Steger, Heidelinde Fiegl, Barin Feroz, et al.
Histochemistry and Cell Biology|February 2, 2012
Differential response of arterial and venous endothelial cells to extracellular matrix is modulated by oxygenLuciana Lassance, Heidi Miedl, Viktoria Konya, et al.
BMC Cancer|January 5, 2018
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)Florian Huemer, Josef Thaler, Gudrun Piringer, et al.
Cell Reports|January 5, 2017
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadePornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Pageof 17